Long term treatment of SSc patients with ET-1 antagonism, in combination with ILO, seems to increase fingertip blood perfusion, as well as both capillary dilation capacity and number. PubMed, J Rheumatol, 2014 Apr 1. (Also see: Bosentan and Treatment for Digital Ulcers: Iloprost)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.